메뉴 건너뛰기




Volumn 33, Issue SUPPL. 2, 2007, Pages

Neoadjuvant treatment before resection of liver metastases

Author keywords

Chemotherapy; Colorectal cancer; Liver metastases

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FERROUS GLUCONATE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; OXALIPLATIN; URACIL;

EID: 36749103860     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.022     Document Type: Review
Times cited : (24)

References (66)
  • 2
    • 0028308472 scopus 로고
    • Factors influencing the natural history of colorectal liver metastases
    • Stangl R., Altendorf-Hofmann A., Charnley R.M., and Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 343 (1994) 1405-1410
    • (1994) Lancet , vol.343 , pp. 1405-1410
    • Stangl, R.1    Altendorf-Hofmann, A.2    Charnley, R.M.3    Scheele, J.4
  • 3
    • 15744374738 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
    • Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038-2048
    • (2005) J Clin Oncol , vol.23 , pp. 2038-2048
    • Leonard, G.D.1    Brenner, B.2    Kemeny, N.E.3
  • 4
    • 0000357764 scopus 로고
    • Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery
    • Nordlinger B., and Jaeck D. (Eds), Springer-Verlag, Paris
    • Nordlinger B., Jaeck D., Guiguet M., Vaillant J.C., Balladur P., and Schaal J.C. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B., and Jaeck D. (Eds). Treatment of hepatic metastases of colorectal cancer (1992), Springer-Verlag, Paris 129-146
    • (1992) Treatment of hepatic metastases of colorectal cancer , pp. 129-146
    • Nordlinger, B.1    Jaeck, D.2    Guiguet, M.3    Vaillant, J.C.4    Balladur, P.5    Schaal, J.C.6
  • 5
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
    • Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
    • (1999) Ann Surg , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 6
    • 0027402072 scopus 로고
    • Hepatectomy for liver metastases
    • Scheele J. Hepatectomy for liver metastases. Br J Surg 80 (1993) 274-276
    • (1993) Br J Surg , vol.80 , pp. 274-276
    • Scheele, J.1
  • 7
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
    • (2000) J Clin Oncol , vol.18 , pp. 2938-2947
    • de Gramont, A.1    Figer, A.2    Seymour, M.3
  • 8
    • 0034712536 scopus 로고    scopus 로고
    • Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
    • Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
    • (2000) Lancet , vol.355 , pp. 1041-1047
    • Douillard, J.Y.1    Cunningham, D.2    Roth, A.D.3
  • 9
    • 0034727063 scopus 로고    scopus 로고
    • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
    • Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343 (2000) 905-914
    • (2000) N Engl J Med , vol.343 , pp. 905-914
    • Saltz, L.B.1    Cox, J.V.2    Blanke, C.3
  • 10
    • 3242720345 scopus 로고    scopus 로고
    • Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    • Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
    • (2004) N Engl J Med , vol.351 , pp. 337-345
    • Cunningham, D.1    Humblet, Y.2    Siena, S.3
  • 11
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 12
    • 33644685360 scopus 로고    scopus 로고
    • Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?
    • Khatri V.P., Petrelli N.J., and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 23 (2005) 8490-8499
    • (2005) J Clin Oncol , vol.23 , pp. 8490-8499
    • Khatri, V.P.1    Petrelli, N.J.2    Belghiti, J.3
  • 13
    • 0343729320 scopus 로고    scopus 로고
    • Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases
    • Lorenz M., Muller H.H., Schramm H., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases. Ann Surg 228 (1998) 756-762
    • (1998) Ann Surg , vol.228 , pp. 756-762
    • Lorenz, M.1    Muller, H.H.2    Schramm, H.3
  • 14
    • 0033619892 scopus 로고    scopus 로고
    • Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
    • Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 (1999) 2039-2048
    • (1999) N Engl J Med , vol.341 , pp. 2039-2048
    • Kemeny, N.1    Huang, Y.2    Cohen, A.M.3
  • 15
    • 0037087721 scopus 로고    scopus 로고
    • Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study
    • Kemeny M.M., Adak S., Gray B., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20 (2002) 1499-1505
    • (2002) J Clin Oncol , vol.20 , pp. 1499-1505
    • Kemeny, M.M.1    Adak, S.2    Gray, B.3
  • 16
    • 33750962938 scopus 로고    scopus 로고
    • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
    • Portier G., Elias D., Bouche O., et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24 (2006) 4976-4982
    • (2006) J Clin Oncol , vol.24 , pp. 4976-4982
    • Portier, G.1    Elias, D.2    Bouche, O.3
  • 17
    • 0345455373 scopus 로고    scopus 로고
    • Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial
    • (abstr 592)
    • Langer B., Bleiberg H., and Labianca R. Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. J Clin Oncol 20 (2002) 149a (abstr 592)
    • (2002) J Clin Oncol , vol.20
    • Langer, B.1    Bleiberg, H.2    Labianca, R.3
  • 18
    • 0041417909 scopus 로고    scopus 로고
    • Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver
    • Tanaka K., Adam R., Shimada H., Azoulay D., Levi F., and Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
    • (2003) Br J Surg , vol.90 , pp. 963-969
    • Tanaka, K.1    Adam, R.2    Shimada, H.3    Azoulay, D.4    Levi, F.5    Bismuth, H.6
  • 19
    • 0037267766 scopus 로고    scopus 로고
    • Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases
    • Allen P.J., Kemeny N., Jarnagin W., DeMatteo R., Blumgart L., and Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 (2003) 109-115
    • (2003) J Gastrointest Surg , vol.7 , pp. 109-115
    • Allen, P.J.1    Kemeny, N.2    Jarnagin, W.3    DeMatteo, R.4    Blumgart, L.5    Fong, Y.6
  • 20
    • 9744226672 scopus 로고    scopus 로고
    • Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
    • Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061
    • (2004) Ann Surg , vol.240 , pp. 1052-1061
    • Adam, R.1    Pascal, G.2    Castaing, D.3
  • 21
    • 33748460684 scopus 로고    scopus 로고
    • Complete response of colorectal liver metastases after chemotherapy: does it mean cure?
    • Benoist S., Brouquet A., Penna C., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 24 (2006) 3939-3945
    • (2006) J Clin Oncol , vol.24 , pp. 3939-3945
    • Benoist, S.1    Brouquet, A.2    Penna, C.3
  • 22
    • 0037256469 scopus 로고    scopus 로고
    • Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
    • Wein A., Riedel C., Bruckl W., et al. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 64 (2003) 131-138
    • (2003) Oncology , vol.64 , pp. 131-138
    • Wein, A.1    Riedel, C.2    Bruckl, W.3
  • 23
    • 20044365047 scopus 로고    scopus 로고
    • Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study
    • Taieb J., Artru P., Paye F., et al. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. J Clin Oncol 23 (2005) 502-509
    • (2005) J Clin Oncol , vol.23 , pp. 502-509
    • Taieb, J.1    Artru, P.2    Paye, F.3
  • 24
    • 33444463163 scopus 로고    scopus 로고
    • Feasibility and risks of pre-operative chemotherapy with folfox 4 and surgery for resectable colorectal liver metastases. Interim results of the EORTC intergroup randomized phase III study 4093
    • (abstr 3528)
    • Nordlinger B., Sorbye H., Debois M., et al. Feasibility and risks of pre-operative chemotherapy with folfox 4 and surgery for resectable colorectal liver metastases. Interim results of the EORTC intergroup randomized phase III study 4093. J Clin Oncol 23 (2005) 253s (abstr 3528)
    • (2005) J Clin Oncol , vol.23
    • Nordlinger, B.1    Sorbye, H.2    Debois, M.3
  • 25
    • 34249948520 scopus 로고    scopus 로고
    • Tumor response to pre-operative xhemotherapy with FOLFOX-4 for resectable colorectal cancer liver metastases. Interim results of EORTC intergroup randomized phase III study 40983
    • (abstr 3500)
    • Gruenberger T., Sorbye H., Debois M., et al. Tumor response to pre-operative xhemotherapy with FOLFOX-4 for resectable colorectal cancer liver metastases. Interim results of EORTC intergroup randomized phase III study 40983. J Clin Oncol 24 (2006) 146s (abstr 3500)
    • (2006) J Clin Oncol , vol.24
    • Gruenberger, T.1    Sorbye, H.2    Debois, M.3
  • 26
    • 0029794696 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    • Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 (1996) 509-520
    • (1996) Ann Surg , vol.224 , pp. 509-520
    • Bismuth, H.1    Adam, R.2    Levi, F.3
  • 27
    • 4644320061 scopus 로고    scopus 로고
    • Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival
    • Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
    • (2004) Ann Surg , vol.240 , pp. 644-657
    • Adam, R.1    Delvart, V.2    Pascal, G.3
  • 28
    • 0035698112 scopus 로고    scopus 로고
    • Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
    • Wein A., Riedel C., Kockerling F., et al. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol 12 (2001) 1721-1727
    • (2001) Ann Oncol , vol.12 , pp. 1721-1727
    • Wein, A.1    Riedel, C.2    Kockerling, F.3
  • 29
    • 0036889745 scopus 로고    scopus 로고
    • Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma
    • Rivoire M., De Cian F., Meeus P., Negrier S., Sebban H., and Kaemmerlen P. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 95 (2002) 2283-2292
    • (2002) Cancer , vol.95 , pp. 2283-2292
    • Rivoire, M.1    De Cian, F.2    Meeus, P.3    Negrier, S.4    Sebban, H.5    Kaemmerlen, P.6
  • 30
    • 2642541197 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients
    • Pozzo C., Basso M., Cassano A., et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15 (2004) 933-939
    • (2004) Ann Oncol , vol.15 , pp. 933-939
    • Pozzo, C.1    Basso, M.2    Cassano, A.3
  • 31
    • 4143148621 scopus 로고    scopus 로고
    • Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients
    • Cals L., Rixe O., Francois E., et al. Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. Ann Oncol 15 (2004) 1018-1024
    • (2004) Ann Oncol , vol.15 , pp. 1018-1024
    • Cals, L.1    Rixe, O.2    Francois, E.3
  • 32
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study
    • Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    Andre, T.2    Achille, E.3
  • 33
    • 33645269821 scopus 로고    scopus 로고
    • Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer
    • (abstr 3593)
    • De La Camara J., Rodriguez J., Rotellar F., et al. Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer. J Clin Oncol 22 (2004) 268s (abstr 3593)
    • (2004) J Clin Oncol , vol.22
    • De La Camara, J.1    Rodriguez, J.2    Rotellar, F.3
  • 34
    • 14344258800 scopus 로고    scopus 로고
    • Resection of previously unresectable liver metastases from colorectal cancer after chemotherapy with CPT11/L-OHP/LV5FU (Folfirinox). A prospective phase II trial
    • (abstr 3613)
    • Quenet F., Nordlinger B., Rivoire M., et al. Resection of previously unresectable liver metastases from colorectal cancer after chemotherapy with CPT11/L-OHP/LV5FU (Folfirinox). A prospective phase II trial. J Clin Oncol 22 (2004) 263s (abstr 3613)
    • (2004) J Clin Oncol , vol.22
    • Quenet, F.1    Nordlinger, B.2    Rivoire, M.3
  • 35
    • 24644432555 scopus 로고    scopus 로고
    • Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986
    • Kohne C.H., van Cutsem E., Wils J., et al. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol 23 (2005) 4856-4865
    • (2005) J Clin Oncol , vol.23 , pp. 4856-4865
    • Kohne, C.H.1    van Cutsem, E.2    Wils, J.3
  • 36
    • 23844544714 scopus 로고    scopus 로고
    • Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group
    • Ho W.M., Ma B., Mok T., et al. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group. Med Oncol 22 (2005) 303-312
    • (2005) Med Oncol , vol.22 , pp. 303-312
    • Ho, W.M.1    Ma, B.2    Mok, T.3
  • 37
    • 20044370825 scopus 로고    scopus 로고
    • Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
    • Seium Y., Stupp R., Ruhstaller T., et al. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 16 (2005) 762-766
    • (2005) Ann Oncol , vol.16 , pp. 762-766
    • Seium, Y.1    Stupp, R.2    Ruhstaller, T.3
  • 38
    • 33644819672 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study
    • Alberts S.R., Horvath W.L., Sternfeld W.C., et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23 (2005) 9243-9249
    • (2005) J Clin Oncol , vol.23 , pp. 9243-9249
    • Alberts, S.R.1    Horvath, W.L.2    Sternfeld, W.C.3
  • 39
    • 20144389169 scopus 로고    scopus 로고
    • Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
    • Delaunoit T., Alberts S.R., Sargent D.J., et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 16 (2005) 425-429
    • (2005) Ann Oncol , vol.16 , pp. 425-429
    • Delaunoit, T.1    Alberts, S.R.2    Sargent, D.J.3
  • 40
    • 30944445619 scopus 로고    scopus 로고
    • Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
    • Masi G., Cupini S., Marcucci L., et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13 (2006) 58-65
    • (2006) Ann Surg Oncol , vol.13 , pp. 58-65
    • Masi, G.1    Cupini, S.2    Marcucci, L.3
  • 41
    • 27244450852 scopus 로고    scopus 로고
    • OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer
    • Poston G.J., Adam R., Alberts S., et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23 (2005) 7125-7134
    • (2005) J Clin Oncol , vol.23 , pp. 7125-7134
    • Poston, G.J.1    Adam, R.2    Alberts, S.3
  • 42
    • 23844448040 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates
    • Folprecht G., Grothey A., Alberts S., Raab H.R., and Kohne C.H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16 (2005) 1311-1319
    • (2005) Ann Oncol , vol.16 , pp. 1311-1319
    • Folprecht, G.1    Grothey, A.2    Alberts, S.3    Raab, H.R.4    Kohne, C.H.5
  • 43
    • 0028858987 scopus 로고
    • Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors
    • Elias D., Lasser P., Rougier P., Ducreux M., Bognel C., and Roche A. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180 (1995) 213-219
    • (1995) J Am Coll Surg , vol.180 , pp. 213-219
    • Elias, D.1    Lasser, P.2    Rougier, P.3    Ducreux, M.4    Bognel, C.5    Roche, A.6
  • 44
    • 0033179745 scopus 로고    scopus 로고
    • Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases
    • Link K.H., Pillasch J., Formentini A., et al. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol 25 (1999) 381-388
    • (1999) Eur J Surg Oncol , vol.25 , pp. 381-388
    • Link, K.H.1    Pillasch, J.2    Formentini, A.3
  • 45
    • 0033862603 scopus 로고    scopus 로고
    • Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy
    • Meric F., Patt Y.Z., Curley S.A., et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7 (2000) 490-495
    • (2000) Ann Surg Oncol , vol.7 , pp. 490-495
    • Meric, F.1    Patt, Y.Z.2    Curley, S.A.3
  • 46
    • 0041880037 scopus 로고    scopus 로고
    • Combined treatment of inoperable liver metastases from colorectal cancer
    • Milandri C., Calzolari F., Giampalma E., et al. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 89 (2003) 112-114
    • (2003) Tumori , vol.89 , pp. 112-114
    • Milandri, C.1    Calzolari, F.2    Giampalma, E.3
  • 47
    • 12444322664 scopus 로고    scopus 로고
    • Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer
    • Mancuso A., Giuliani R., Accettura C., et al. Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. Anticancer Res 23 (2003) 1917-1922
    • (2003) Anticancer Res , vol.23 , pp. 1917-1922
    • Mancuso, A.1    Giuliani, R.2    Accettura, C.3
  • 48
    • 36749096053 scopus 로고    scopus 로고
    • Second-look hepatectomy after pharmacokinetic modulating chemotherapy combination with hepatic arterial 5FU infusion and oral UFT in patients with unresectable hepatic colorectal metastases
    • (abstr 3739)
    • Noda M., Yanagi H., Yoshikawa R., Yamamura T., and Kusunoki M. Second-look hepatectomy after pharmacokinetic modulating chemotherapy combination with hepatic arterial 5FU infusion and oral UFT in patients with unresectable hepatic colorectal metastases. J Clin Oncol 22 (2004) 303s (abstr 3739)
    • (2004) J Clin Oncol , vol.22
    • Noda, M.1    Yanagi, H.2    Yoshikawa, R.3    Yamamura, T.4    Kusunoki, M.5
  • 49
    • 24644484863 scopus 로고    scopus 로고
    • Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
    • Kemeny N., Jarnagin W., Paty P., et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23 (2005) 4888-4896
    • (2005) J Clin Oncol , vol.23 , pp. 4888-4896
    • Kemeny, N.1    Jarnagin, W.2    Paty, P.3
  • 50
    • 24644443860 scopus 로고    scopus 로고
    • Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
    • Ducreux M., Ychou M., Laplanche A., et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23 (2005) 4881-4887
    • (2005) J Clin Oncol , vol.23 , pp. 4881-4887
    • Ducreux, M.1    Ychou, M.2    Laplanche, A.3
  • 51
    • 33646493925 scopus 로고    scopus 로고
    • Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy
    • Selzner N., Pestalozzi B.C., Kadry Z., Selzner M., Wildermuth S., and Clavien P.A. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J Surg 93 (2006) 587-592
    • (2006) Br J Surg , vol.93 , pp. 587-592
    • Selzner, N.1    Pestalozzi, B.C.2    Kadry, Z.3    Selzner, M.4    Wildermuth, S.5    Clavien, P.A.6
  • 52
    • 33645450153 scopus 로고    scopus 로고
    • Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
    • Kemeny N.E., Niedzwiecki D., Hollis D.R., et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24 (2006) 1395-1403
    • (2006) J Clin Oncol , vol.24 , pp. 1395-1403
    • Kemeny, N.E.1    Niedzwiecki, D.2    Hollis, D.R.3
  • 53
    • 16244372110 scopus 로고    scopus 로고
    • Cetuximab + FOLFIRI as first-line treatment for metastatic colorectal cancer
    • (abstr 3513)
    • Rougier P., Raoul J.-L., Van Laethem J.-L., et al. Cetuximab + FOLFIRI as first-line treatment for metastatic colorectal cancer. J Clin Oncol 22 (2004) 248s (abstr 3513)
    • (2004) J Clin Oncol , vol.22
    • Rougier, P.1    Raoul, J.-L.2    Van Laethem, J.-L.3
  • 54
    • 6444230253 scopus 로고    scopus 로고
    • A phase II study of gefitinib in combination with FOLFOX-4 in patients with metastatic colorectal cancer
    • (abstr 3514)
    • Fischer G.A., Kuo T., Cho C.D., et al. A phase II study of gefitinib in combination with FOLFOX-4 in patients with metastatic colorectal cancer. J Clin Oncol 22 (2004) 248s (abstr 3514)
    • (2004) J Clin Oncol , vol.22
    • Fischer, G.A.1    Kuo, T.2    Cho, C.D.3
  • 55
    • 36749079691 scopus 로고    scopus 로고
    • An international phase II study of cetuximab in combination with FOLFOX-4 in the first-line treatment of patients with metastatic colorectal cancer expressing epidermal growth factor receptor. Preliminary results
    • (abstr 3535)
    • Diaz Rubio E., Tabernero J.M., Van Cutsem E., et al. An international phase II study of cetuximab in combination with FOLFOX-4 in the first-line treatment of patients with metastatic colorectal cancer expressing epidermal growth factor receptor. Preliminary results. J Clin Oncol 23 (2005) 254s (abstr 3535)
    • (2005) J Clin Oncol , vol.23
    • Diaz Rubio, E.1    Tabernero, J.M.2    Van Cutsem, E.3
  • 56
    • 33644697486 scopus 로고    scopus 로고
    • Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
    • Folprecht G., Lutz M.P., Schoffski P., et al. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol 17 (2006) 450-456
    • (2006) Ann Oncol , vol.17 , pp. 450-456
    • Folprecht, G.1    Lutz, M.P.2    Schoffski, P.3
  • 57
    • 11144354740 scopus 로고    scopus 로고
    • Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    • Rubbia-Brandt L., Audard V., Sartoretti P., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 (2004) 460-466
    • (2004) Ann Oncol , vol.15 , pp. 460-466
    • Rubbia-Brandt, L.1    Audard, V.2    Sartoretti, P.3
  • 58
    • 10744231437 scopus 로고    scopus 로고
    • Impact of steatosis on perioperative outcome following hepatic resection
    • Kooby D.A., Fong Y., Suriawinata A., et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7 (2003) 1034-1044
    • (2003) J Gastrointest Surg , vol.7 , pp. 1034-1044
    • Kooby, D.A.1    Fong, Y.2    Suriawinata, A.3
  • 59
    • 19744365905 scopus 로고    scopus 로고
    • Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
    • Fernandez F.G., Ritter J., Goodwin J.W., Linehan D.C., Hawkins W.G., and Strasberg S.M. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200 (2005) 845-853
    • (2005) J Am Coll Surg , vol.200 , pp. 845-853
    • Fernandez, F.G.1    Ritter, J.2    Goodwin, J.W.3    Linehan, D.C.4    Hawkins, W.G.5    Strasberg, S.M.6
  • 60
    • 33644822617 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
    • Bilchik A.J., Poston G., Curley S.A., et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 23 (2005) 9073-9078
    • (2005) J Clin Oncol , vol.23 , pp. 9073-9078
    • Bilchik, A.J.1    Poston, G.2    Curley, S.A.3
  • 61
    • 30144435398 scopus 로고    scopus 로고
    • Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
    • Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
    • (2006) Ann Surg , vol.243 , pp. 1-7
    • Karoui, M.1    Penna, C.2    Amin-Hashem, M.3
  • 62
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
    • (2006) J Clin Oncol , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3
  • 63
    • 33750957147 scopus 로고    scopus 로고
    • Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
    • Aloia T., Sebagh M., Plasse M., et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24 (2006) 4983-4990
    • (2006) J Clin Oncol , vol.24 , pp. 4983-4990
    • Aloia, T.1    Sebagh, M.2    Plasse, M.3
  • 64
    • 33750961459 scopus 로고    scopus 로고
    • Benefits and risks of neoadjuvant therapy for liver metastases
    • Nordlinger B., and Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 24 (2006) 4954-4955
    • (2006) J Clin Oncol , vol.24 , pp. 4954-4955
    • Nordlinger, B.1    Benoist, S.2
  • 65
    • 0031781467 scopus 로고    scopus 로고
    • Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
    • Peppercorn P.D., Reznek R.H., Wilson P., Slevin M.L., and Gupta R.K. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77 (1998) 2008-2011
    • (1998) Br J Cancer , vol.77 , pp. 2008-2011
    • Peppercorn, P.D.1    Reznek, R.H.2    Wilson, P.3    Slevin, M.L.4    Gupta, R.K.5
  • 66
    • 24644454338 scopus 로고    scopus 로고
    • Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab
    • Ellis L.M., Curley S.A., and Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23 (2005) 4853-4855
    • (2005) J Clin Oncol , vol.23 , pp. 4853-4855
    • Ellis, L.M.1    Curley, S.A.2    Grothey, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.